These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 32812633)
1. Uric Acid Is Not Associated With Blood Pressure Phenotypes and Target Organ Damage According to Blood Pressure Phenotypes. Cai A; Liu L; Siddiqui M; Zhou D; Chen J; Calhoun DA; Tang S; Zhou Y; Feng Y Am J Hypertens; 2021 Feb; 34(1):64-72. PubMed ID: 32812633 [TBL] [Abstract][Full Text] [Related]
2. Impact of Uric Acid on Hypertension Occurrence and Target Organ Damage: Insights From the STANISLAS Cohort With a 20-Year Follow-up. Kanbay M; Girerd N; Machu JL; Bozec E; Duarte K; Boivin JM; Wagner S; Ferreira JP; Zannad F; Rossignol P Am J Hypertens; 2020 Sep; 33(9):869-878. PubMed ID: 32267470 [TBL] [Abstract][Full Text] [Related]
3. Association of hyperuricemia and hypertension phenotypes in hypertensive patients without uric acid lowering treatment. Liu C; Qiu D; Zhang M; Hou J; Lin J; Liao H Clin Exp Hypertens; 2021 Aug; 43(6):516-521. PubMed ID: 33775186 [TBL] [Abstract][Full Text] [Related]
4. The controversial role of serum uric acid in essential hypertension: relationships with indices of target organ damage. Tsioufis C; Chatzis D; Vezali E; Dimitriadis K; Antoniadis D; Zervoudaki A; Lalos S; Kallikazaros I; Stefanadis C; Toutouzas P J Hum Hypertens; 2005 Mar; 19(3):211-7. PubMed ID: 15647779 [TBL] [Abstract][Full Text] [Related]
5. Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia. Cuspidi C; Valerio C; Sala C; Meani S; Esposito A; Zanchetti A; Mancia G Am J Hypertens; 2007 Jun; 20(6):678-85. PubMed ID: 17531928 [TBL] [Abstract][Full Text] [Related]
6. High serum uric acid is associated to poorly controlled blood pressure and higher arterial stiffness in hypertensive subjects. Cicero AF; Rosticci M; Fogacci F; Grandi E; D'Addato S; Borghi C; Eur J Intern Med; 2017 Jan; 37():38-42. PubMed ID: 27498274 [TBL] [Abstract][Full Text] [Related]
10. Isolated ambulatory hypertension and changes in target organ damage in treated hypertensive patients. Cuspidi C; Meani S; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A J Hum Hypertens; 2005 Jun; 19(6):471-7. PubMed ID: 15744331 [TBL] [Abstract][Full Text] [Related]
11. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients. Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044 [TBL] [Abstract][Full Text] [Related]
12. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes. Ayala DE; Moyá A; Crespo JJ; Castiñeira C; Domínguez-Sardiña M; Gomara S; Sineiro E; Mojón A; Fontao MJ; Hermida RC; Chronobiol Int; 2013 Mar; 30(1-2):99-115. PubMed ID: 23098178 [TBL] [Abstract][Full Text] [Related]
13. Blood Pressure Control in Hypertensive Patients, Cardiovascular Risk Profile and the Prevalence of Masked Uncontrolled Hypertension (MUCH). Naser N; Dzubur A; Durak A; Kulic M; Naser N Med Arch; 2016 Jul; 70(4):274-279. PubMed ID: 27703288 [TBL] [Abstract][Full Text] [Related]
14. Uric Acid, Hypertensive Phenotypes, and Organ Damage: Data from the Pamela Study. Grassi G; Vanoli J; Facchetti R; Mancia G Curr Hypertens Rep; 2022 Feb; 24(2):29-35. PubMed ID: 35076878 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of target organ damage in treated hypertensive patients: different impact of clinic and ambulatory blood pressure control. Cuspidi C; Lonati L; Sampieri L; Michev I; Macca G; Rocanova JI; Salerno M; Fusi V; Leonetti G; Zanchetti A J Hypertens; 2000 Jun; 18(6):803-9. PubMed ID: 10872567 [TBL] [Abstract][Full Text] [Related]
16. The frequency of combined target organ damage and the beneficial effect of ambulatory blood pressure monitoring in never treated mild-to-moderate hypertensive patients. Torun D; Sezer S; Arat Z; Pelit A; Yigit F; Ozdemir FN Int Heart J; 2005 Nov; 46(6):1073-82. PubMed ID: 16394603 [TBL] [Abstract][Full Text] [Related]
17. White coat effect and masked uncontrolled hypertension in treated hypertensive-diabetic patients: Prevalence and target organ damage. Leiria LF; Severo MD; Ledur PS; Becker AD; Aguiar FM; Massierer D; Freitas VC; Schaan BD; Gus M J Diabetes; 2015 Sep; 7(5):699-707. PubMed ID: 25327439 [TBL] [Abstract][Full Text] [Related]
18. Absence of an independent association between serum uric acid and left ventricular mass in Caucasian hypertensive women and men. Mulè G; Nardi E; Costanzo M; Mogavero M; Guarino L; Viola T; Vario MG; Cacciatore V; Andronico G; Cerasola G; Cottone S Nutr Metab Cardiovasc Dis; 2013 Aug; 23(8):715-22. PubMed ID: 22494808 [TBL] [Abstract][Full Text] [Related]
19. Ambulatory Blood Pressure Phenotypes in Adults Taking Antihypertensive Medication with and without CKD. Mwasongwe SE; Tanner RM; Poudel B; Pugliese DN; Young BA; Abdalla M; Musani SK; Gutiérrez OM; Correa A; Shimbo D; Muntner P Clin J Am Soc Nephrol; 2020 Apr; 15(4):501-510. PubMed ID: 32217635 [TBL] [Abstract][Full Text] [Related]
20. Ambulatory blood pressure is better associated with target organ damage than clinic blood pressure in patients with primary glomerular disease. Wen RW; Chen XQ; Zhu Y; Ke JT; Du Y; Wang C; Lou TQ BMC Nephrol; 2020 Dec; 21(1):541. PubMed ID: 33308181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]